Company Monitoring Page for Eisai

latest headlines for company on cafepharma

Eisai cuts the ribbon on $69M injectable drug delivery facility
Fierce Pharma
Tue, 10/11/22 - 10:26 am
Tags:
Eisai, injectables, drug delivery, R&D
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks, AbbVie, Alnylam, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, GSK, Intellia Therapeutics, Regeneron, Roche, Sanofi, Sarepta Therapeutics
Biotech’s near-term key catalysts
EP Vantage
Thu, 09/29/22 - 09:45 am
Tags:
Biogen, Eisai, Alzheimer's disease, Arrowhead Pharmaceuticals, Takeda, RNAi, Madrigal, NASH, Ascendis, FDA
Lecanemab can; now the wait for details begins
EP Vantage
Wed, 09/28/22 - 11:45 am
Tags:
Biogen, Eisai, lecanemab, clinical trials, Alzheimer's disease
Biogen/Eisai Alzheimer’s treatment slowed cognitive decline in closely watched clinical trial
Stat
Wed, 09/28/22 - 12:04 am
Tags:
Biogen, Eisai, Alzheimer's disease, clinical trials, lecanemab
Eisai inaugurates new US HQ as closely watched FDA Alzheimer's decision draws near
Fierce Pharma
Sun, 08/21/22 - 09:36 pm
Tags:
Eisai, headquarters, Alzheimer's disease, FDA
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
Tags:
layoffs, hirings, Astellas, Pfizer, Eikon Therapeutics, Bayer, Avadel Pharma, Heron Therapeutics, Adverum Biotechnologies, Biogen, Eisai, X4 Pharmaceuticals, Assembly Biosciences
Eisai closing oncology R&D wing H3 Biomedicine for good
Fierce Biotech
Mon, 07/18/22 - 07:23 pm
Tags:
Eisai, oncology, H3 Biomedicine, layoffs, R&D
Biogen-Eisai go for another biomarker approval in Alzheimer's with lecanemab—and snag priority review
Fierce Biotech
Tue, 07/5/22 - 11:58 pm
Tags:
Biogen, Eisai, FDA, biomarkers, Alzheimer's disease, lecanemab
ASCO22: New data backs BMS’ investment in Eisai’s first cancer ADC
Pharmaforum
Mon, 06/6/22 - 11:52 pm
Tags:
ASCO 2022, Eisai, antibody-drug conjugate, Bristol Myers Squibb, MORAb-202
Simulation model shows potential clinical value of Eisai drug for patients with early AD
Biopharma Reporter
Mon, 05/9/22 - 10:15 am
Tags:
Eisai, Alzheimer's disease, lecanemab
Biogen shoves Aduhelm to the side. It's time for lecanemab
Fierce Biotech
Wed, 05/4/22 - 10:33 am
Tags:
Biogen, Aduhelm, lecanemab, Eisai, Alzheimer's disease
Biogen, Eisai unveil new data on lecanemab, but questions linger on ARIA-E; Spatial biology outfit grabs $33M round
Endpoints
Tue, 03/22/22 - 11:19 pm
Tags:
Eisai, Biogen, lecanemab, Alzheimer's disease
Eisai hands off responsibility for Aduhelm to Biogen
Pharmaforum
Tue, 03/15/22 - 11:43 am
Tags:
Eisai, Biogen, Aduhelm, Alzheimer's disease
Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase 1/2 soon
Fierce Biotech
Mon, 02/14/22 - 12:05 pm
Tags:
Hemavant, Roivant Sciences, Eisai, MDS, RVT-2001
Eisai bites back against restricted coverage plan for Aduhelm
Pharmaforum
Thu, 02/10/22 - 10:16 am
Tags:
Eisai, Biogen, Aduhelm, Alzheimer's disease, FDA, CMS
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
Tags:
FDA, adagrasib, donanemab, faricimab, lecanemab, tezepelumab, tirzepatide, vutrisiran, Eli Lilly, Mirati Therapeutics, Roche, Chugai, Eisai, Biogen, AstraZeneca, Amgen, Alnylam
Biogen and Eisai move forward with investigational Alzheimer's therapy
Biopharma Reporter
Mon, 01/3/22 - 10:45 pm
Tags:
Biogen, Eisai, lecanemab, Alzheimer's disease, fast track, FDA
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Tags:
Alnylam Pharmaceuticals, Bio-Thera Solutions, BioArctic, Biogen, BridgeBio Pharma, Daiichi Sankyo, Eisai, JNJ, Madrigal Pharmaceuticals, Merck, Sutro BioPharma, Tasly Pharmaceutical Group
Biogen-Eisai's potential Aduhelm sequel drug granted speedy review by FDA
Fierce Biotech
Tue, 12/28/21 - 10:55 am
Tags:
Biogen, Eisai, lecanemab, FDA, Aduhelm, fast track, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.